Author Question: For patients receiving PN, ___________ provide supplemental kilocalories and prevent essential fatty ... (Read 30 times)

brutforce

  • Hero Member
  • *****
  • Posts: 540
For patients receiving PN, ___________ provide supplemental kilocalories and prevent essential fatty acid deficiencies.
 
  Fill in the blanks with correct word

Question 2

The patient is on the dysphagia puree stage of the national dysphagia diet. Which of the following foods may the patient select?
 
  a. Mashed potatoes
  b. Dry cereals moistened with milk
  c. Well-cooked noodles in gravy
  d. Well-moistened cereals



b614102004

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

lipids
Lipids provide supplemental kilocalories and prevent essential fatty acid deficiencies.

Answer to Question 2

A
The dysphagia puree stage requires foods that are uniform, pureed, and cohesive with a pudding-like texture. Examples include mashed potatoes, pureed meat, pureed pasta, yogurt, and cooked cereals. Dry cereals moistened with milk and well-cooked noodles in gravy are allowed in the dysphagia mechanically altered stage. Well-moistened cereals are allowed in the dysphagia advanced stage.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

On average, the stomach produces 2 L of hydrochloric acid per day.

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library